Stanford researchers discover immune cells migrate into brain during aging

For decades, neuroscientists have operated from a foundational assumption: the brain runs its own immune system, sealed off from the body by the blood-brain barrier, staffed by resident immune cells called microglia that have been there since birth and need no reinforcement from outside. It was a clean model. It was also, according to Stanford researchers, incomplete.

In work published in Nature on July 30, 2026, Julia Belk and her colleagues at Stanford Medicine demonstrated that the aging brain does not remain closed at all. Instead, immune cells from the bloodstream migrate into the brain over decades, arriving as early as middle age and transforming into the specialized microglia that patrol neural tissue. The finding upends a cornerstone of modern neuroscience and suggests that what happens in the body's blood and bone marrow may directly shape the health of the brain itself.

Belk, a postdoctoral scholar in pathology, came to this work through an unusual path. As a graduate student in computer science, she trained in the Chemistry/Biology Interface Predoctoral Program, an experience she credits with teaching her to move fluidly between disciplines. That training proved essential when she began collaborating with Siddhartha Jaiswal, an associate professor of pathology at Stanford Medicine. Together, they were investigating a curious pattern: people who carried certain mutated clones of immune cells—a condition called clonal hematopoiesis of indeterminate potential—showed lower rates of Alzheimer's disease. The question was why. If these mutant cells could somehow reach the brain, perhaps they were doing something protective there.

To trace the journey of immune cells from blood to brain, Belk and her team needed a method that could prove lineage across the blood-brain barrier. They turned to DNA itself. Because immune cells divide constantly as we age, mutations accumulate in the blood stem cells that produce them. These mutations get passed down like genetic breadcrumbs. If the same mutations appeared in both blood samples and brain tissue from the same person, the researchers could be confident that the brain's immune cells were descendants of cells that originated in the bloodstream—much like tracing ancestry through shared genetic markers. Working with tissue from the Stanford Rapid Autopsy Center and the University of Washington's Alzheimer's Disease Sequencing Project, they compared immune cells from people with and without Alzheimer's, looking for these telltale matches.

They found them. The DNA evidence showed that immune cells had indeed crossed from the body into the brain, and that these peripheral cells had transformed into microglia. Remarkably, this appears to be a distinctly human phenomenon. The same pattern does not occur in mice or non-human primates, making it a feature of human aging that had gone undetected until now.

The implications ripple outward in multiple directions. If immune cells can reach the brain, then researchers might engineer them to do useful work there—cells designed to break down the amyloid and tau proteins that accumulate in Alzheimer's disease, for instance, delivered as a preventative therapy before damage begins. More broadly, the discovery suggests that factors affecting blood stem cells and bone marrow function could influence the risk of neurological disease by altering the microglia population. Jaiswal noted that the life history of blood stem cells may shape brain disease risk in ways previously invisible to science.

For Belk, the excitement lies partly in the practical possibilities but also in the simple fact of discovery itself. "This is a uniquely human feature of aging that we had no idea about," she said. The brain, it turns out, is not the closed system neuroscience long believed it to be. It is permeable, dynamic, and shaped by processes unfolding in the body below.